Search research articles
Contact Us
Filters
Showing results (131-140 of 201) with videos related to
Page
of 21
Sort By:
International Journal of Oncology
|
July 13, 2005
Assessment of the significance of mitochondrial DNA damage by chemotherapeutic agents
Soo Lo, Berend Tolner, Jan-Willem Taanman, et al.
Annals of Neurology
|
October 5, 2012
Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains
Matthew E Gegg, Derek Burke, Simon J R Heales, et al.
Diabetes Care
|
March 21, 2020
Effects of Intensive Glycemic Control on Clinical Outcomes Among Patients With Type 2 Diabetes With Different Levels of Cardiovascular Risk and Hemoglobin A<sub>1c</sub> in the ADVANCE Trial
Jingyan Tian, Toshiaki Ohkuma, Mark Cooper, et al.
Journal of Experimental Botany
|
May 31, 2022
Radiation use efficiency increased over a century of maize (Zea mays L.) breeding in the US corn belt
Carlos D Messina, Jose Rotundo, Graeme L Hammer, et al.
Archives of Neurology
|
August 11, 2010
Chaperone-mediated autophagy markers in Parkinson disease brains
Lydia Alvarez-Erviti, Maria C Rodriguez-Oroz, J Mark Cooper, et al.
Neurology
|
February 22, 2013
A novel α-synuclein missense mutation in Parkinson disease
Christos Proukakis, Christopher G Dudzik, Timothy Brier, et al.
Diabetes Care
|
May 10, 2014
Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial
Yoichiro Hirakawa, Hisatomi Arima, Sophia Zoungas, et al.
Cardiovascular Diabetology
|
July 29, 2017
Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
Kamel Mohammedi, Mark Woodward, Michel Marre, et al.
Heart, Lung & Circulation
|
October 12, 2016
Intensive LDL Reduction Post Acute Coronary Syndromes: A Catalyst for Improved Outcomes
Karam Kostner, Stephen Nicholls, John Amerena, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 24, 2003
Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease
Jin H Li, Xiao R Huang, Hong-Jian Zhu, et al.
Page
of 21
Search research articles
Search
Showing results (131-140 of 201) with videos related to
Sort By:
Page
of 21
International Journal of Oncology
|
July 13, 2005
Assessment of the significance of mitochondrial DNA damage by chemotherapeutic agents
Soo Lo, Berend Tolner, Jan-Willem Taanman, et al.
Annals of Neurology
|
October 5, 2012
Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains
Matthew E Gegg, Derek Burke, Simon J R Heales, et al.
Diabetes Care
|
March 21, 2020
Effects of Intensive Glycemic Control on Clinical Outcomes Among Patients With Type 2 Diabetes With Different Levels of Cardiovascular Risk and Hemoglobin A<sub>1c</sub> in the ADVANCE Trial
Jingyan Tian, Toshiaki Ohkuma, Mark Cooper, et al.
Journal of Experimental Botany
|
May 31, 2022
Radiation use efficiency increased over a century of maize (Zea mays L.) breeding in the US corn belt
Carlos D Messina, Jose Rotundo, Graeme L Hammer, et al.
Archives of Neurology
|
August 11, 2010
Chaperone-mediated autophagy markers in Parkinson disease brains
Lydia Alvarez-Erviti, Maria C Rodriguez-Oroz, J Mark Cooper, et al.
Neurology
|
February 22, 2013
A novel α-synuclein missense mutation in Parkinson disease
Christos Proukakis, Christopher G Dudzik, Timothy Brier, et al.
Diabetes Care
|
May 10, 2014
Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial
Yoichiro Hirakawa, Hisatomi Arima, Sophia Zoungas, et al.
Cardiovascular Diabetology
|
July 29, 2017
Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
Kamel Mohammedi, Mark Woodward, Michel Marre, et al.
Heart, Lung & Circulation
|
October 12, 2016
Intensive LDL Reduction Post Acute Coronary Syndromes: A Catalyst for Improved Outcomes
Karam Kostner, Stephen Nicholls, John Amerena, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 24, 2003
Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease
Jin H Li, Xiao R Huang, Hong-Jian Zhu, et al.
Page
of 21